Best Practices

In January, the U.S. FDA said a preliminary review showed no evidence of such a link, though the agency said it could not rule out that ‘a small risk may exist.’

A new article in the Journal of Pain looked at the results of 16 randomized, double-blind trials published on CBD and pain since 2019.

A 24-week randomized clinical trial compares low-dose oral minoxidil and topical minoxidil solution for male androgenetic alopecia.

Drinks promoted as offering mental or physical benefits beyond hydration are growing in popularity.

This year had the highest ratio of residents matched to residency programs in the past seven years.

Protection may extend to female partners, suggesting prophylactic potential.

How do pharmacists feel about their role as OTC advisors in 2024? Here are just a few highlights from the survey . . .

The U.S. Food and Drug Administration’s accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients’ lives?